Edition:
United States

Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

112.98USD
18 May 2018
Change (% chg)

$-2.55 (-2.21%)
Prev Close
$115.53
Open
$114.70
Day's High
$114.70
Day's Low
$112.44
Volume
19,255
Avg. Vol
22,179
52-wk High
$128.25
52-wk Low
$93.59

Chart for

About

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical... (more)

Overall

Beta: 0.66
Market Cap(Mil.): $4,633.05
Shares Outstanding(Mil.): 40.10
Dividend: --
Yield (%): --

Financials

  TARO.N Industry Sector
P/E (TTM): 21.96 28.57 32.53
EPS (TTM): 5.15 -- --
ROI: 9.84 13.08 12.63
ROE: 9.92 14.80 14.50

BRIEF-Taro Pharmaceutical Industries Reports Q4 EPS $2.17

* FY EARNINGS PER SHARE $6.18 EXCLUDING ITEMS Source text for Eikon: Further company coverage:

May 17 2018

BRIEF-Taro Pharmaceutical Industries Posts Q3 Earnings Per Share $0.45

* ‍EXCLUDING IMPACT OF ONE-TIME TAX RE-MEASUREMENT, EARNINGS PER SHARE FOR QUARTER WOULD BE $1.37​ Source text for Eikon: Further company coverage:

Feb 07 2018

BRIEF-Bellus Health Receives Milestone Payment From Taro Pharmaceuticals

* BELLUS HEALTH RECEIVES MILESTONE PAYMENT FROM TARO PHARMACEUTICALS Source text for Eikon: Further company coverage:

Jan 09 2018

Earnings vs. Estimates